Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy

Nature

Volumn 319, Issue 6055, 1986, Pages 675-678

  Kärre, Klas ^a   Ljunggren, Hans Gustaf ^a   Piontek, Gerald ^a   Kiessling, Rolf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; CANCER; H2 SYSTEM; LYMPHOMA CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REJECTION;

ANIMAL; GRAFT REJECTION; H-2 ANTIGENS; IMMUNE TOLERANCE; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; NEOPLASM TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022616253     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/319675a0     Document Type: Article

References (41)

1. Bumet, F. M. Nature 232, 230-235 (1971).
2. Zinkemagel, R. M. and Doherty, P. C. J. exp. Med. 141, 1427-1436 (1975).
3. Doherty, P. C., Knowles, B. B. and Wettstein, P. J. Adv. Cancer Res. 42, 1-66 (1984).
4. Sanderson, A. R. and Beverley, P. C. L. Immun. Today 4, 211-213 (1983).
5. Kärre, K. thesis, Karolinska Inst. (1981).
6. Karre, K. in Mechanisms of Cytoxicity by Natural Killer Cells (eds Herberman, R. B. and Callewaert, D.) 81-91 (Academic, Orlando, 1985).
7. Kärre, K., Klein, G. O., Kiessling, R., Klein, G. and Roder, J. C. Int. J. Cancer 26, 789-797.
8. Klein, J. in Biology of the Mouse Histocompatibility-2 Complex, 36-37 (Springer, New York, 1975).
9. Boon, R. Adv. Cancer Res. 39, 121-151 (1983).
10. Frost, P., Kerbel, R. S., Bauer, E., Tartanella-Biondo, R. and Cefalu, W. Cancer Res. 43, 125-132 (1983).
11. Hui, K., Grosvels, F. and Festenstein, H. Nature 311, 750-752 (1984).
12. Hämmerling, G. J. et al Nature 315, 301-306 (1985).
13. Bevan, M. J. J. exp. Med. 142, 1349-1364 (1975).
14. Cudkowicz, G. and Hochman, P. S. Immun. Rev. 44, 13-41 (1979).
15. Cikes, M., Friberg, S. Jr and Klein, G. J. natn. Cancer Inst. 30, 347-361 (1973).
16. Stem, P. et al Nature 285, 341-342 (1982).
17. Hansson, M. et al J. Immun. 123, 765-771 (1979).
18. Carlson, G. A., Melnychuk, D. and Meeker, M. J. Int. J. Cancer 25, 111-122 (1980).
19. Hansson, M., Kiessling, R., Andersson, B. and Welsh, R. M. J. Immun. 125, 2225-2231 (1980).
20. Becker, S., Kiessling, R., Lee, N. and Klein, G. J. natn. Cancer Inst. 61, 1493-1498 (1978).
21. Cudkowicz, G. and Bennet, M. J. exp. Med. 134, 1513-1528 (1971).
22. Klein, G. O., Klein, G., Kiessling, R. and Kärre, K. Immunogenetics 6, 561-569 (1978).
23. Rolstad, B. and Ford, W. L. Immun. Rev. 73, 87-114 (1983).
24. Möller, E. J. natn. Cancer Inst. 33, 979-987 (1964).
25. Haywood, G. R. and McKhann, C. J. exp. Med. 133, 1171-1187 (1971).
26. Katzav, S., De Baetselier, P., Tarbakovsky, B., Feldman, M. and Segal, S. J. natn. Cancer Inst. 71, 317-324 (1983).
27. Eisenbach, L., Segal, S. and Feldman, M. Int. J. Cancer 32, 113-120 (1983).
28. Gooding, L. R. J. Immun. 129, 1306-1312 (1982).
29. Schrier, P. I., Bernards, R., Vaessen, J., Houweling, A. and van der Eb, A. J. Nature 305, 771-775 (1983).
30. Gidlund, M. et al Nature 292, 848-850 (1981).
31. Scofield, V. L., Schlumpberger, J. M., West, L. A. and Weissman, I. L. Nature 295, 499-502
32. Hecht, T. and Summers, D. J. Virol. 10, 378-385 (1972).
33. Welsh, R. M., Kärre, K., Hansson, M., Kunkel, L. A. and Kiessling, R. J. Immun. 126, 219-225.
34. Snell, G. Transplantn Proc. 8, 147-156 (1976).
35. Dausset, J. Devi comp. Immun. 5, 1-4 (1981).
36. Brickell, P. M., Latchman, D., Murphy, D., Wilson, K. and Rigby, P. W. J. Nature 306, 756-761 (1984).
37. Baldacci, P., Pozo, F., Gisselbrecht, S. and Kourilsky, P. J. exp. Med. 158, 1294-1306 (1981).
38. Ozato, K. and Sachs, D. H. J. Immun. 126, 317-321 (1981).
39. Kärre, K., Seeley, J., Eriksson, E., Burton, R. and Kiessling, R. J. exp. Med. 156, 385-403 (1983).
40. Julius, M. H., Simpson, E. and Herzenberg, L. A. Eur. J. immun. 3, 645-651 (1973).
41. Piontek, G. et al. J. Immun. 135, 4281-4288 (1985).